Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Neoplastic Diseases of the Blood
In this fourth edition of the classic work on malignant blood cancers, the team of editors and over 100 international leaders in the field provide a comprehensive text on the diagnosis and treatment of all hematologic malignancies, both common and rare. The sixty-two chapters are divided into sections on Chronic Leukemias and Related Disorders, Acute Leukemias, Myeloma and Related Disorders, Lymphomas, and Supportive Care, with a devoted editor for each section. This extensively revised and updated edition reflects the tremendous progress in the science and treatment of hematologic malignancies during the eight years since the third edition in 1995. Revisions and new chapters include coverage of stem cell transplantation, molecular genetics, monoclonal antibodies, and new treatment modalities. The excellent discussions of current therapies for all hematologic neoplasms are more detailed than those in general oncology or hematology texts, making this an essential reference for all hematologists and oncologists.
General Condition and Comorbidity of Long-term Survivors of Adult Acute Lymphoblastic Leukemia
Abstract: Cure rates in adult acute lymphoblastic leukemia (ALL) improved using pediatric-based chemotherapy and stem cell transplantation (SCT). However, limited data on the health condition of cured adults are available whereas pediatric data cannot be transferred. The GMALL analyzed the health status in survivors of adult ALL retrospectively. Physicians answered a questionnaire on general condition (Eastern Cooperative Oncology Group [ECOG] status) and comorbidity or syndrome occurrence observed after treatment. Five hundred and thirty-eight patients with a median age of 29 (range, 15-64) years at diagnosis were analyzed, median follow-up was 7 (range, 3-24) years. Thirty-one percent had received SCT. ECOG status was 0-1 in 94%, 34% had not developed significant comorbidities. Most frequent comorbidities involved the neurologic system (27%), endocrine system (20%), skin (18%), graft-versus-host-disease (15%), cardiac system (13%), fatigue (13%). SCT impacted ECOG status and comorbidity occurrence significantly. ECOG 0-1 was observed in 86% of SCT and 98% of non-SCT patients (P
Acute Lymphoblastic Leukemia
This volume integrates information ranging from molecular biology to the use of bone marrow transplants in the treatment of acute lymphoblastic leukemia (ALL). Focusing on controversial issues, this volume unites basic research and clinical data in evaluating recent progress and pointing out areas for future investigations in leukemia diagnosis and therapy. Timely studies of oncogenes, retroviruses and chromosome alterations provide important data on the mechanistic and developmental aspects of"
Cytokines in the Treatment of Hematopoietic Failure
Written by world experts in the field, this book presents up-to-date, in-depth coverage of hematopoietic growth factors and related cytokines that are currently being developed or used for managing congenital and acquired forms of chronic cytopenias. Summarizes important clinical trial data in a convenient tabulated format and provides fundamental knowledge on hematopoiesis physiology and regulation! Facilitating rational decision making and cost-effective treatment strategies, this clinically and disease-oriented work describes as well as assesses the benefits and limitations of hematopoietic growth factor and cytokine use in graft failure peripheral-blood progenitor cell transplantation ch...
Textbook of Malignant Haematology
This textbook provides a concise overview of malignant haematology, including reviews of cell and molecular biology, and implications for new trends in treatment.
